Latest Amides Stories
Three pivotal trials showed PRADAXA as non-inferior to warfarin in reduction of DVT and PE recurrence; fourth pivotal trial showed PRADAXA reduced risk of recurrence by 92 percent compared to placebo RIDGEFIELD,
Boehringer Ingelheim ordered to pay nearly $1 million fine for obstructing pre-trial evidence gathering.
The Firm is investigating Byetta lawsuits on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer due to their use of Byetta. New
The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news.
Cardiologists also believe their patients' top concern is the fear of experiencing a clot that leads to a stroke; real-world challenges may influence treatment decisions RIDGEFIELD, Conn.,
Presentations to include research around antidote for dabigatran, a post-hoc analysis of data from the RE-LY® trial and data from the GLORIA(TM)-AF registry RIDGEFIELD, Conn., March 24, 2014
Results Show Highest Rate of Control Ever Observed with Warfarin in Real-world Setting, Surpassing Thresholds for Cost-Effectiveness of Newer Agents Identified in Five Recent Independent Studies
Federal Judge Overseeing More than 2,300 Pradaxa Lawsuits Schedules Four Bellwether Trials, First of Which Will Begin in September 2014. Columbus, OH (PRWEB)
http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news.
- In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
- In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.